Evidence map›Paper›PMID 27916806›Full record

ArticleMolecules (Basel, Switzerland)2016

Antifungal Activity of Oleuropein against Candida albicans-The In Vitro Study.

Nataša Zorić, Nevenka Kopjar, Ivan Bobnjarić, Igor Horvat, Siniša Tomić, Ivan Kosalec

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Vidarabine as a novel antifungal agent against Candida albicans: insights on mechanism of action.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Targeting Virulence Factors ofFoods (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nataša ZorićAgency for Medicinal Products and Medical Devices of Croatia (HALMED), Ksaverska cesta 4, HR-10000 Zagreb, Croatia. natasa.zoric@halmed.hr.
Nevenka KopjarInstitute for Medical Research and Occupational Health, Ksaverska cesta 2, HR-10000 Zagreb, Croatia. nkopjar@imi.hr.
Ivan BobnjarićDepartment of Microbiology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Schrottova 39, HR-10000 Zagreb, Croatia. ivan.bobnjaric@gmail.com.
Igor HorvatDepartment of Microbiology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Schrottova 39, HR-10000 Zagreb, Croatia. igor.horvat@gmail.com.
Siniša TomićAgency for Medicinal Products and Medical Devices of Croatia (HALMED), Ksaverska cesta 4, HR-10000 Zagreb, Croatia. sinisa.tomic@halmed.hr.
Ivan KosalecDepartment of Microbiology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Schrottova 39, HR-10000 Zagreb, Croatia. ikosalec@pharma.hr.
University of Zagreb · HRAgency for Medicinal Products and Medical Devices of Croatia · HRInstitute for Medical Research and Occupational Health · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study we investigated activity of oleuropein, a complex phenol present in large quantities in olive tree products, against opportunistic fungal pathogen

Indexed as

Antifungal AgentsApoptosisCandida albicansCell AdhesionHydrophobic and Hydrophilic InteractionsIridoid GlucosidesIridoidsMicrobial Sensitivity TestsOleaPlant PreparationsVirulence FactorsAntifungal AgentsIridoid GlucosidesIridoidsoleuropeinPlant PreparationsVirulence Factorsantifungal activityCandida albicansoleuropeinvirulence factors

Identifiers

PMID27916806
PMCPMC6273721
OpenAlexW2558558010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.